These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17979676)

  • 1. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
    Seiler MP; Cerullo V; Lee B
    Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
    Vetrini F; Ng P
    Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper-dependent adenoviral vectors for liver-directed gene therapy.
    Brunetti-Pierri N; Ng P
    Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in helper-dependent adenoviral vector--a review review].
    Fu Y; He J; Shi C; Hong T
    Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):147-52. PubMed ID: 19445167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.
    Mane VP; Toietta G; McCormack WM; Conde I; Clarke C; Palmer D; Finegold MJ; Pastore L; Ng P; Lopez J; Lee B
    Gene Ther; 2006 Sep; 13(17):1272-80. PubMed ID: 16708078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
    Brunetti-Pierri N; Ng P
    Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.
    Descamps D; Benihoud K
    Curr Gene Ther; 2009 Apr; 9(2):115-27. PubMed ID: 19355869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in helper-dependent adenoviral vector research.
    Segura MM; Alba R; Bosch A; Chillón M
    Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient attenuation of NK cell-mediated liver injury through genetically manipulating multiple immunogenes by using a liver-directed vector.
    Geng J; Wang X; Wei H; Sun R; Tian Z
    J Immunol; 2013 May; 190(9):4821-9. PubMed ID: 23554312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy.
    Brunetti-Pierri N; Ng P
    Curr Opin Mol Ther; 2006 Oct; 8(5):446-54. PubMed ID: 17078387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
    Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
    Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper-dependent adenoviral vectors for gene therapy.
    Palmer DJ; Ng P
    Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
    Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
    O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
    Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.
    Zhu J; Huang X; Yang Y
    J Virol; 2007 Apr; 81(7):3170-80. PubMed ID: 17229689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery.
    Kushwah R; Cao H; Hu J
    J Immunol; 2008 Mar; 180(6):4098-108. PubMed ID: 18322220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice.
    Fu YH; He JS; Zheng XX; Wang XB; Xie C; Shi CX; Zhang M; Tang Q; Wei W; Qu JG; Hong T
    Biochem Biophys Res Commun; 2010 Jan; 391(1):857-61. PubMed ID: 19945423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
    Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
    Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng P
    Gene Ther; 2008 Apr; 15(8):553-60. PubMed ID: 18288209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.